Last reviewed · How we verify
NCT04713124: R2C-M
A Telephone-delievered Intervention to Reduce Methamphetamine Use
NA trial testing R2C-M in Methamphetamine Use Disorder in 204 participants. Completed in 25 January 2024.
1 May 2023
Quick facts
| Lead sponsor | Turning Point |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 204 |
| Start date | 4 February 2021 |
| Primary completion | 1 May 2023 |
| Estimated completion | 25 January 2024 |
| Sites | 1 location across Australia |
Drugs / interventions tested
- R2C-M
- Self-help booklet
Conditions studied
- Methamphetamine Use Disorder — all drugs for Methamphetamine Use Disorder →
Sponsor
Turning Point — full company profile →
Who can join
18 and older, any sex, with Methamphetamine Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Australia has one of the highest rates of methamphetamine use in the world; however, uptake of face-to-face psychological treatment remains extremely low due to numerous individual (e.g. stigma, shame) and structural (e.g. service availability, geography) barriers to accessing care. Addressing these barriers through the provision of alternative treatment delivery models is imperative, particularly as effective and earlier intervention is likely to reduce the need for more costly and intensive treatment resulting from escalating methamphetamine use. In this project, the investigators will conduct the first double-blind, parallel-group, randomised controlled trial (RCT) examining the effectiveness of the structured telephone-delivered intervention, Ready2Change (R2C), among participants with methamphetamine use problems (R2C-M). Cost effectiveness of R2C-M will also be investigated. Factors influencing program implementation will be evaluated to inform the scalability of this intervention for practice nationally, and for replication internationally.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A structured, telephone-delivered intervention to reduce methamphetamine use: study protocol for a parallel-group randomised controlled trial.
Lubman DI, Manning V, Arunogiri S, Hall K, et al · · 2023 · cited 1× · PMID 36991490 · DOI 10.1186/s13063-023-07172-9 -
A structured, telephone-delivered intervention to reduce methamphetamine use: Study protocol for a parallel group randomised controlled trial
Lubman D, Manning V, Arunogiri S, Hall K, et al · · 2023 · DOI 10.21203/rs.3.rs-2399893/v1
Verify or expand the search:
- PubMed search for NCT04713124
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Methamphetamine Use Disorder
Currently open trials in the same condition.
- NCT07226596 — Non-Abstinence Outcomes in Methamphetamine Use Disorder · NA · recruiting
- NCT07450027 — LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis · recruiting
- NCT06989853 — Methamphetamine and Troriluzole · EARLY_PHASE1 · recruiting
- NCT07459244 — ECG Findings in Methamphetamine Use · recruiting
- NCT06712446 — A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder · NA · recruiting
Other Turning Point trials
Trials by the same sponsor.
- NCT06019442 — An Electronic Brief Alcohol Intervention for Women Attending a Breast Screening Service (Health4Her) · NA · completed
- NCT05760807 — Intranasal Oxytocin for Methamphetamine Withdrawal in Women · NA · completed
- NCT04923256 — AAT-APP+: A Novel Brain-training App to Reduce Drinking · NA · completed
- NCT05120856 — AAT-App Outpatient Trial · NA · completed
- NCT04715516 — Increasing Knowledge of Alcohol as a Risk Factor for Breast Cancer Among Women Attending Breast Screening Services · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04713124 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Turning Point
- Last refreshed: 7 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04713124.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing